| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enterocolitis, Necrotizing | 27 | 2024 | 89 | 11.330 |
Why?
|
| Infant, Newborn, Diseases | 4 | 2023 | 44 | 3.010 |
Why?
|
| Infant, Premature, Diseases | 7 | 2023 | 37 | 3.010 |
Why?
|
| Infant, Newborn | 30 | 2024 | 851 | 2.660 |
Why?
|
| Enterobacteriaceae Infections | 7 | 2020 | 13 | 2.630 |
Why?
|
| Child | 29 | 2024 | 2164 | 1.990 |
Why?
|
| Infant | 21 | 2024 | 970 | 1.800 |
Why?
|
| Humans | 71 | 2024 | 27090 | 1.750 |
Why?
|
| Intussusception | 2 | 2022 | 6 | 1.610 |
Why?
|
| Fetal Diseases | 2 | 2023 | 18 | 1.610 |
Why?
|
| Intestines | 7 | 2023 | 117 | 1.580 |
Why?
|
| rho-Associated Kinases | 3 | 2020 | 12 | 1.460 |
Why?
|
| Intestinal Mucosa | 11 | 2022 | 186 | 1.400 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2022 | 36 | 1.400 |
Why?
|
| Biomedical Research | 2 | 2021 | 93 | 1.390 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2024 | 46 | 1.360 |
Why?
|
| Infant, Premature | 10 | 2023 | 133 | 1.260 |
Why?
|
| Epithelial Cells | 5 | 2019 | 240 | 1.210 |
Why?
|
| Anti-Bacterial Agents | 10 | 2024 | 497 | 1.190 |
Why?
|
| Appendicitis | 4 | 2024 | 14 | 1.170 |
Why?
|
| Surgeons | 3 | 2024 | 49 | 1.140 |
Why?
|
| Cronobacter sakazakii | 6 | 2020 | 6 | 1.100 |
Why?
|
| Child, Preschool | 14 | 2019 | 1098 | 1.070 |
Why?
|
| Catheterization, Central Venous | 3 | 2017 | 36 | 1.060 |
Why?
|
| Retrospective Studies | 21 | 2021 | 2461 | 1.050 |
Why?
|
| Intestinal Perforation | 3 | 2019 | 13 | 1.030 |
Why?
|
| Female | 35 | 2023 | 14610 | 1.010 |
Why?
|
| Cronobacter | 2 | 2016 | 2 | 0.960 |
Why?
|
| Reactive Nitrogen Species | 1 | 2024 | 10 | 0.930 |
Why?
|
| Hernia, Ventral | 1 | 2024 | 11 | 0.900 |
Why?
|
| Abdominal Injuries | 1 | 2024 | 29 | 0.880 |
Why?
|
| Disease Models, Animal | 9 | 2020 | 1405 | 0.880 |
Why?
|
| Postoperative Complications | 8 | 2019 | 606 | 0.880 |
Why?
|
| Appendix | 3 | 2021 | 9 | 0.880 |
Why?
|
| Male | 30 | 2022 | 12997 | 0.870 |
Why?
|
| Ethics, Medical | 2 | 2024 | 11 | 0.860 |
Why?
|
| Oxidation-Reduction | 1 | 2024 | 353 | 0.850 |
Why?
|
| Pediatrics | 1 | 2024 | 87 | 0.820 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 279 | 0.820 |
Why?
|
| Enterocolitis | 1 | 2022 | 4 | 0.800 |
Why?
|
| Physicians | 1 | 2023 | 80 | 0.780 |
Why?
|
| Consumer Advocacy | 1 | 2021 | 10 | 0.770 |
Why?
|
| Social Justice | 1 | 2021 | 12 | 0.760 |
Why?
|
| Financing, Organized | 1 | 2021 | 5 | 0.750 |
Why?
|
| Organizational Innovation | 1 | 2021 | 19 | 0.750 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 121 | 0.750 |
Why?
|
| Staphylococcal Infections | 1 | 2022 | 81 | 0.740 |
Why?
|
| Up-Regulation | 2 | 2019 | 240 | 0.740 |
Why?
|
| Biopsy | 2 | 2018 | 201 | 0.710 |
Why?
|
| Rats | 10 | 2020 | 1544 | 0.710 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2019 | 143 | 0.710 |
Why?
|
| Animals | 17 | 2024 | 10062 | 0.690 |
Why?
|
| Cadherins | 1 | 2020 | 24 | 0.690 |
Why?
|
| Amides | 1 | 2020 | 18 | 0.680 |
Why?
|
| Oxidative Stress | 1 | 2024 | 630 | 0.680 |
Why?
|
| Internship and Residency | 1 | 2023 | 225 | 0.660 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2019 | 2 | 0.660 |
Why?
|
| Watchful Waiting | 2 | 2018 | 18 | 0.650 |
Why?
|
| Soft Tissue Infections | 1 | 2019 | 10 | 0.650 |
Why?
|
| Claudin-2 | 1 | 2019 | 4 | 0.650 |
Why?
|
| Organoids | 1 | 2019 | 21 | 0.650 |
Why?
|
| Liver | 3 | 2018 | 423 | 0.640 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 447 | 0.640 |
Why?
|
| Pyridines | 1 | 2020 | 102 | 0.640 |
Why?
|
| Parenteral Nutrition, Total | 2 | 2018 | 5 | 0.640 |
Why?
|
| Abscess | 1 | 2019 | 24 | 0.640 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2019 | 39 | 0.620 |
Why?
|
| Occludin | 1 | 2018 | 11 | 0.610 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2019 | 30 | 0.610 |
Why?
|
| Caveolin 1 | 1 | 2019 | 43 | 0.610 |
Why?
|
| Cholestasis | 1 | 2018 | 10 | 0.610 |
Why?
|
| Ultrasonography, Mammary | 1 | 2018 | 3 | 0.610 |
Why?
|
| Surgical Wound Infection | 2 | 2016 | 104 | 0.600 |
Why?
|
| Professional Competence | 2 | 2008 | 36 | 0.600 |
Why?
|
| Models, Biological | 2 | 2019 | 448 | 0.600 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 61 | 0.590 |
Why?
|
| Breast | 1 | 2018 | 54 | 0.590 |
Why?
|
| Lipopolysaccharides | 4 | 2022 | 155 | 0.570 |
Why?
|
| Evidence-Based Medicine | 2 | 2008 | 141 | 0.560 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 33 | 0.550 |
Why?
|
| Appendectomy | 4 | 2024 | 14 | 0.540 |
Why?
|
| Cyclic AMP | 1 | 2016 | 83 | 0.540 |
Why?
|
| Laparotomy | 2 | 2022 | 29 | 0.530 |
Why?
|
| Adolescent | 14 | 2020 | 2989 | 0.520 |
Why?
|
| Overweight | 1 | 2016 | 108 | 0.510 |
Why?
|
| Unnecessary Procedures | 1 | 2015 | 7 | 0.510 |
Why?
|
| Meningitis, Bacterial | 2 | 2013 | 9 | 0.510 |
Why?
|
| Follow-Up Studies | 8 | 2019 | 986 | 0.510 |
Why?
|
| Hospital Costs | 1 | 2015 | 29 | 0.500 |
Why?
|
| Skull Fractures | 1 | 2015 | 18 | 0.500 |
Why?
|
| MicroRNAs | 1 | 2019 | 279 | 0.490 |
Why?
|
| Caco-2 Cells | 3 | 2020 | 5 | 0.490 |
Why?
|
| Treatment Outcome | 11 | 2020 | 2281 | 0.490 |
Why?
|
| Toes | 1 | 2014 | 3 | 0.480 |
Why?
|
| Genitalia | 1 | 2014 | 8 | 0.480 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 353 | 0.480 |
Why?
|
| Fingers | 1 | 2014 | 16 | 0.480 |
Why?
|
| Hair | 1 | 2014 | 15 | 0.480 |
Why?
|
| Edema | 1 | 2014 | 18 | 0.480 |
Why?
|
| Catheterization, Peripheral | 1 | 2015 | 24 | 0.480 |
Why?
|
| Teratoma | 3 | 2017 | 17 | 0.470 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2019 | 538 | 0.470 |
Why?
|
| Blood Vessels | 1 | 2015 | 58 | 0.460 |
Why?
|
| Ischemia | 1 | 2014 | 83 | 0.460 |
Why?
|
| Apoptosis | 6 | 2016 | 738 | 0.450 |
Why?
|
| Vascular Diseases | 1 | 2015 | 67 | 0.450 |
Why?
|
| Disease Management | 1 | 2014 | 85 | 0.450 |
Why?
|
| Hospitalization | 1 | 2015 | 193 | 0.450 |
Why?
|
| Food Microbiology | 2 | 2013 | 23 | 0.440 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2024 | 467 | 0.440 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2019 | 128 | 0.440 |
Why?
|
| Esophageal Atresia | 2 | 2009 | 3 | 0.430 |
Why?
|
| Diagnosis, Differential | 5 | 2019 | 368 | 0.420 |
Why?
|
| Sepsis | 2 | 2013 | 81 | 0.420 |
Why?
|
| Household Articles | 1 | 2012 | 6 | 0.410 |
Why?
|
| Jejunal Diseases | 1 | 2012 | 3 | 0.410 |
Why?
|
| Jejunum | 1 | 2012 | 8 | 0.410 |
Why?
|
| Intestinal Obstruction | 1 | 2012 | 9 | 0.410 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 446 | 0.410 |
Why?
|
| Acrylic Resins | 1 | 2012 | 13 | 0.410 |
Why?
|
| Foreign Bodies | 1 | 2012 | 16 | 0.410 |
Why?
|
| Tight Junctions | 2 | 2022 | 29 | 0.380 |
Why?
|
| Obesity | 1 | 2016 | 651 | 0.360 |
Why?
|
| Nitric Oxide | 2 | 2008 | 152 | 0.360 |
Why?
|
| alpha-Fetoproteins | 2 | 2017 | 18 | 0.360 |
Why?
|
| Funnel Chest | 3 | 2020 | 5 | 0.360 |
Why?
|
| Prostheses and Implants | 1 | 2009 | 27 | 0.340 |
Why?
|
| Pectus Carinatum | 2 | 2020 | 2 | 0.340 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2009 | 23 | 0.320 |
Why?
|
| Surveys and Questionnaires | 3 | 2023 | 927 | 0.320 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2009 | 9 | 0.320 |
Why?
|
| Adult | 7 | 2024 | 7481 | 0.320 |
Why?
|
| Lactobacillus | 1 | 2008 | 14 | 0.320 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2008 | 7 | 0.310 |
Why?
|
| Neuroblastoma | 2 | 2014 | 56 | 0.310 |
Why?
|
| Animals, Newborn | 5 | 2020 | 177 | 0.310 |
Why?
|
| Elective Surgical Procedures | 2 | 2021 | 70 | 0.310 |
Why?
|
| Sex Factors | 2 | 2021 | 451 | 0.300 |
Why?
|
| Colon | 3 | 2017 | 119 | 0.300 |
Why?
|
| Probiotics | 1 | 2008 | 17 | 0.300 |
Why?
|
| Pancreatic Pseudocyst | 1 | 2007 | 3 | 0.300 |
Why?
|
| Emergency Service, Hospital | 3 | 2015 | 119 | 0.290 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 463 | 0.290 |
Why?
|
| Urinary Tract Infections | 1 | 2007 | 39 | 0.290 |
Why?
|
| Pancreas | 1 | 2007 | 58 | 0.280 |
Why?
|
| Kidney Neoplasms | 1 | 2007 | 100 | 0.270 |
Why?
|
| Central Venous Catheters | 2 | 2017 | 6 | 0.270 |
Why?
|
| Catheter-Related Infections | 2 | 2017 | 13 | 0.260 |
Why?
|
| Biomarkers, Tumor | 1 | 2009 | 377 | 0.260 |
Why?
|
| Enterocytes | 4 | 2009 | 14 | 0.250 |
Why?
|
| Surgical Procedures, Operative | 2 | 2024 | 46 | 0.250 |
Why?
|
| Incidence | 5 | 2020 | 553 | 0.250 |
Why?
|
| Academic Medical Centers | 2 | 2023 | 73 | 0.240 |
Why?
|
| Faculty, Medical | 2 | 2023 | 51 | 0.240 |
Why?
|
| Antimicrobial Stewardship | 1 | 2024 | 5 | 0.230 |
Why?
|
| Algorithms | 2 | 2019 | 421 | 0.230 |
Why?
|
| Inventions | 1 | 2024 | 4 | 0.230 |
Why?
|
| Young Adult | 4 | 2021 | 2627 | 0.220 |
Why?
|
| Accidents, Traffic | 1 | 2024 | 27 | 0.220 |
Why?
|
| Permeability | 2 | 2022 | 59 | 0.220 |
Why?
|
| Survival Rate | 2 | 2019 | 409 | 0.220 |
Why?
|
| Operating Rooms | 1 | 2023 | 17 | 0.210 |
Why?
|
| Claudins | 1 | 2022 | 8 | 0.210 |
Why?
|
| Tight Junction Proteins | 1 | 2022 | 9 | 0.210 |
Why?
|
| Biopsy, Needle | 3 | 2013 | 47 | 0.210 |
Why?
|
| Parturition | 1 | 2022 | 16 | 0.210 |
Why?
|
| Medicine | 1 | 2023 | 22 | 0.210 |
Why?
|
| Isoquinolines | 1 | 2022 | 14 | 0.200 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 438 | 0.200 |
Why?
|
| United States | 2 | 2019 | 2058 | 0.200 |
Why?
|
| Antioxidants | 1 | 2024 | 222 | 0.200 |
Why?
|
| Risk Assessment | 2 | 2019 | 594 | 0.200 |
Why?
|
| Combined Modality Therapy | 3 | 2018 | 292 | 0.200 |
Why?
|
| Tertiary Care Centers | 1 | 2021 | 26 | 0.190 |
Why?
|
| Authorship | 1 | 2021 | 13 | 0.190 |
Why?
|
| Blotting, Western | 2 | 2016 | 506 | 0.190 |
Why?
|
| Radiography | 2 | 2015 | 201 | 0.190 |
Why?
|
| Clinical Competence | 1 | 2023 | 204 | 0.190 |
Why?
|
| Writing | 1 | 2021 | 14 | 0.190 |
Why?
|
| Drainage | 2 | 2019 | 42 | 0.180 |
Why?
|
| Biomarkers | 2 | 2023 | 736 | 0.180 |
Why?
|
| Guidelines as Topic | 1 | 2021 | 44 | 0.180 |
Why?
|
| Infection Control | 1 | 2021 | 31 | 0.180 |
Why?
|
| Immunohistochemistry | 4 | 2012 | 455 | 0.180 |
Why?
|
| Perioperative Care | 1 | 2021 | 35 | 0.180 |
Why?
|
| RNA, Messenger | 1 | 2022 | 647 | 0.180 |
Why?
|
| Ultrasonography | 2 | 2019 | 229 | 0.180 |
Why?
|
| Chest Pain | 1 | 2020 | 25 | 0.180 |
Why?
|
| Attitude of Health Personnel | 1 | 2021 | 139 | 0.180 |
Why?
|
| Preoperative Care | 2 | 2019 | 76 | 0.170 |
Why?
|
| Milk, Human | 2 | 2014 | 82 | 0.170 |
Why?
|
| Cytochrome P-450 Enzyme Inducers | 1 | 2020 | 1 | 0.170 |
Why?
|
| Pregnancy | 2 | 2022 | 1147 | 0.170 |
Why?
|
| Echocardiography | 1 | 2020 | 108 | 0.170 |
Why?
|
| Pilot Projects | 1 | 2021 | 397 | 0.170 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 111 | 0.170 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2020 | 93 | 0.160 |
Why?
|
| Pandemics | 1 | 2021 | 167 | 0.160 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 59 | 0.160 |
Why?
|
| Laparoscopy | 2 | 2011 | 143 | 0.160 |
Why?
|
| Actin Cytoskeleton | 1 | 2019 | 23 | 0.160 |
Why?
|
| Clinical Protocols | 1 | 2019 | 45 | 0.160 |
Why?
|
| Sleep Wake Disorders | 1 | 2020 | 65 | 0.160 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 92 | 0.160 |
Why?
|
| Cell Membrane Permeability | 1 | 2019 | 42 | 0.160 |
Why?
|
| Heart | 1 | 2020 | 221 | 0.160 |
Why?
|
| Reconstructive Surgical Procedures | 1 | 2020 | 72 | 0.160 |
Why?
|
| Enzyme Inhibitors | 1 | 2020 | 247 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 234 | 0.160 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 129 | 0.160 |
Why?
|
| Thoracic Wall | 1 | 2018 | 11 | 0.160 |
Why?
|
| Braces | 1 | 2018 | 6 | 0.160 |
Why?
|
| Cholagogues and Choleretics | 1 | 2018 | 3 | 0.160 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2018 | 3 | 0.160 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2019 | 69 | 0.150 |
Why?
|
| Recurrence | 1 | 2019 | 316 | 0.150 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 50 | 0.150 |
Why?
|
| Skin | 1 | 2019 | 140 | 0.150 |
Why?
|
| Optical Imaging | 1 | 2018 | 30 | 0.150 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 108 | 0.150 |
Why?
|
| Resuscitation | 2 | 2008 | 59 | 0.150 |
Why?
|
| Parenteral Nutrition | 2 | 2015 | 8 | 0.150 |
Why?
|
| Foreign-Body Migration | 1 | 2017 | 8 | 0.140 |
Why?
|
| Fever | 1 | 2017 | 30 | 0.140 |
Why?
|
| Risk Factors | 4 | 2016 | 2035 | 0.140 |
Why?
|
| Equipment Failure | 1 | 2017 | 31 | 0.140 |
Why?
|
| Virus Diseases | 1 | 2017 | 38 | 0.140 |
Why?
|
| Protein Binding | 1 | 2019 | 635 | 0.140 |
Why?
|
| Cathartics | 1 | 2017 | 11 | 0.140 |
Why?
|
| Rectum | 1 | 2017 | 50 | 0.140 |
Why?
|
| Ultrasonography, Interventional | 1 | 2017 | 38 | 0.140 |
Why?
|
| Risk | 1 | 2017 | 133 | 0.140 |
Why?
|
| Swine | 1 | 2017 | 220 | 0.140 |
Why?
|
| Bacterial Infections | 1 | 2017 | 56 | 0.140 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 160 | 0.140 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 111 | 0.140 |
Why?
|
| Guideline Adherence | 1 | 2017 | 91 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2008 | 365 | 0.130 |
Why?
|
| Time Factors | 2 | 2019 | 1572 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 262 | 0.130 |
Why?
|
| Chicago | 1 | 2015 | 6 | 0.130 |
Why?
|
| Body Weight | 1 | 2016 | 247 | 0.130 |
Why?
|
| Neurologic Examination | 1 | 2015 | 21 | 0.130 |
Why?
|
| Age Factors | 1 | 2018 | 721 | 0.130 |
Why?
|
| Flow Cytometry | 1 | 2016 | 285 | 0.130 |
Why?
|
| Anastomosis, Surgical | 3 | 2009 | 37 | 0.130 |
Why?
|
| Venae Cavae | 1 | 2015 | 1 | 0.120 |
Why?
|
| Pleural Cavity | 1 | 2015 | 1 | 0.120 |
Why?
|
| Diseases in Twins | 1 | 2015 | 4 | 0.120 |
Why?
|
| Pleural Effusion | 1 | 2015 | 14 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2014 | 1372 | 0.120 |
Why?
|
| Neuregulins | 1 | 2014 | 1 | 0.120 |
Why?
|
| Receptor, ErbB-4 | 1 | 2014 | 1 | 0.120 |
Why?
|
| Syndrome | 1 | 2014 | 78 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 665 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 810 | 0.120 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2014 | 1 | 0.120 |
Why?
|
| Neoplasms, Neuroepithelial | 1 | 2014 | 9 | 0.110 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2014 | 10 | 0.110 |
Why?
|
| Thoracic Neoplasms | 1 | 2014 | 9 | 0.110 |
Why?
|
| Image-Guided Biopsy | 1 | 2013 | 20 | 0.110 |
Why?
|
| Endoscopy, Digestive System | 1 | 2013 | 19 | 0.110 |
Why?
|
| Aged | 2 | 2021 | 5213 | 0.110 |
Why?
|
| Opportunistic Infections | 1 | 2013 | 14 | 0.110 |
Why?
|
| Liver Diseases | 1 | 2013 | 51 | 0.110 |
Why?
|
| Sterilization | 1 | 2013 | 8 | 0.110 |
Why?
|
| Infant Formula | 1 | 2013 | 18 | 0.110 |
Why?
|
| Cyanosis | 1 | 2012 | 3 | 0.110 |
Why?
|
| Enteral Nutrition | 2 | 2010 | 21 | 0.110 |
Why?
|
| Virulence Factors | 1 | 2013 | 45 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2012 | 39 | 0.100 |
Why?
|
| Mice | 3 | 2017 | 4464 | 0.100 |
Why?
|
| Campylobacter | 1 | 2012 | 5 | 0.100 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2012 | 43 | 0.100 |
Why?
|
| Campylobacter Infections | 1 | 2012 | 11 | 0.100 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 68 | 0.100 |
Why?
|
| Hypertension, Portal | 1 | 2012 | 5 | 0.100 |
Why?
|
| Middle Aged | 2 | 2021 | 6888 | 0.100 |
Why?
|
| Ileus | 1 | 2011 | 7 | 0.100 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 2011 | 5 | 0.100 |
Why?
|
| Arteriovenous Malformations | 1 | 2012 | 16 | 0.100 |
Why?
|
| Abdominal Abscess | 1 | 2011 | 9 | 0.100 |
Why?
|
| Interleukin-10 | 1 | 2012 | 67 | 0.100 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2012 | 46 | 0.090 |
Why?
|
| Gestational Age | 2 | 2009 | 141 | 0.090 |
Why?
|
| Ovarian Neoplasms | 1 | 2017 | 566 | 0.090 |
Why?
|
| Gastrostomy | 1 | 2010 | 6 | 0.090 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2009 | 1 | 0.090 |
Why?
|
| Stomach | 1 | 2009 | 42 | 0.080 |
Why?
|
| Radiography, Abdominal | 1 | 2009 | 7 | 0.080 |
Why?
|
| Gastroschisis | 1 | 2008 | 6 | 0.080 |
Why?
|
| Short Bowel Syndrome | 1 | 2008 | 4 | 0.080 |
Why?
|
| Infant Food | 1 | 2008 | 11 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2008 | 80 | 0.080 |
Why?
|
| Infant, Low Birth Weight | 1 | 2008 | 23 | 0.080 |
Why?
|
| Intestine, Small | 1 | 2008 | 66 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 188 | 0.080 |
Why?
|
| Intensive Care, Neonatal | 1 | 2008 | 17 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 324 | 0.070 |
Why?
|
| Rare Diseases | 1 | 2007 | 7 | 0.070 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2009 | 94 | 0.070 |
Why?
|
| Nephrectomy | 1 | 2007 | 47 | 0.070 |
Why?
|
| Disease Susceptibility | 1 | 2008 | 72 | 0.070 |
Why?
|
| Ligands | 1 | 2008 | 168 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2007 | 388 | 0.070 |
Why?
|
| Iatrogenic Disease | 1 | 2006 | 13 | 0.070 |
Why?
|
| Prognosis | 1 | 2009 | 762 | 0.070 |
Why?
|
| Factor VIIa | 1 | 2006 | 29 | 0.070 |
Why?
|
| Dermatofibrosarcoma | 1 | 2006 | 1 | 0.070 |
Why?
|
| Eczema | 1 | 2006 | 2 | 0.070 |
Why?
|
| Polypropylenes | 1 | 2006 | 6 | 0.070 |
Why?
|
| Sutures | 1 | 2006 | 15 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2008 | 211 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2018 | 1223 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2006 | 128 | 0.060 |
Why?
|
| Blood | 2 | 2017 | 33 | 0.060 |
Why?
|
| Inflammation | 1 | 2008 | 605 | 0.050 |
Why?
|
| Brain | 1 | 2009 | 707 | 0.050 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2023 | 6 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2018 | 404 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2021 | 67 | 0.050 |
Why?
|
| Health Facilities | 1 | 2021 | 11 | 0.050 |
Why?
|
| Reoperation | 2 | 2013 | 144 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2021 | 89 | 0.040 |
Why?
|
| Length of Stay | 2 | 2014 | 218 | 0.040 |
Why?
|
| Asymptomatic Diseases | 1 | 2020 | 17 | 0.040 |
Why?
|
| Actigraphy | 1 | 2020 | 22 | 0.040 |
Why?
|
| Suture Techniques | 2 | 2010 | 28 | 0.040 |
Why?
|
| Analgesics | 1 | 2020 | 35 | 0.040 |
Why?
|
| Intraoperative Complications | 2 | 2012 | 47 | 0.040 |
Why?
|
| Cytokines | 2 | 2014 | 438 | 0.040 |
Why?
|
| Sleep | 1 | 2020 | 101 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2019 | 67 | 0.040 |
Why?
|
| Thorax | 1 | 2018 | 28 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2018 | 75 | 0.040 |
Why?
|
| Urine | 1 | 2017 | 14 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2018 | 191 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2017 | 166 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 203 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2017 | 103 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 253 | 0.030 |
Why?
|
| Paneth Cells | 1 | 2014 | 8 | 0.030 |
Why?
|
| Ileum | 1 | 2014 | 23 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 312 | 0.030 |
Why?
|
| Ganglioneuroblastoma | 1 | 2014 | 1 | 0.030 |
Why?
|
| Ganglioneuroma | 1 | 2014 | 4 | 0.030 |
Why?
|
| Neurofibromatosis 1 | 1 | 2014 | 6 | 0.030 |
Why?
|
| Electrocoagulation | 1 | 2014 | 20 | 0.030 |
Why?
|
| Rhabdoid Tumor | 1 | 2014 | 9 | 0.030 |
Why?
|
| Paraspinal Muscles | 1 | 2014 | 10 | 0.030 |
Why?
|
| Neurilemmoma | 1 | 2014 | 13 | 0.030 |
Why?
|
| Los Angeles | 1 | 2013 | 13 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2013 | 32 | 0.030 |
Why?
|
| Postoperative Hemorrhage | 1 | 2013 | 30 | 0.030 |
Why?
|
| Heart Septal Defects | 1 | 2012 | 10 | 0.030 |
Why?
|
| Scotland | 1 | 2012 | 4 | 0.030 |
Why?
|
| Population Density | 1 | 2012 | 21 | 0.030 |
Why?
|
| Tetralogy of Fallot | 1 | 2012 | 22 | 0.030 |
Why?
|
| Zoonoses | 1 | 2012 | 13 | 0.030 |
Why?
|
| Pregnancy, Animal | 1 | 2012 | 12 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2012 | 34 | 0.020 |
Why?
|
| Water Microbiology | 1 | 2012 | 63 | 0.020 |
Why?
|
| Data Collection | 1 | 2012 | 101 | 0.020 |
Why?
|
| Immunocompetence | 1 | 2011 | 6 | 0.020 |
Why?
|
| Gangrene | 1 | 2011 | 4 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 148 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 2011 | 14 | 0.020 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2011 | 11 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 163 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2013 | 861 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 509 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 144 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 2009 | 34 | 0.020 |
Why?
|
| Blood Bactericidal Activity | 1 | 2009 | 7 | 0.020 |
Why?
|
| Gliosis | 1 | 2009 | 17 | 0.020 |
Why?
|
| Intestinal Atresia | 1 | 2008 | 1 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2009 | 19 | 0.020 |
Why?
|
| Atrophy | 1 | 2008 | 14 | 0.020 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2008 | 7 | 0.020 |
Why?
|
| Pneumonia | 1 | 2009 | 89 | 0.020 |
Why?
|
| Intracranial Hemorrhages | 1 | 2009 | 30 | 0.020 |
Why?
|
| Comorbidity | 1 | 2009 | 251 | 0.020 |
Why?
|
| Anthropometry | 1 | 2008 | 94 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 1494 | 0.020 |
Why?
|
| Coccyx | 1 | 2006 | 2 | 0.020 |
Why?
|
| Trauma Severity Indices | 1 | 2006 | 37 | 0.020 |
Why?
|
| Sacrum | 1 | 2006 | 23 | 0.020 |
Why?
|
| Spinal Neoplasms | 1 | 2006 | 39 | 0.020 |
Why?
|
| Foreign-Body Reaction | 1 | 2006 | 3 | 0.020 |
Why?
|
| Dermatitis, Contact | 1 | 2006 | 7 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 408 | 0.020 |
Why?
|
| Mutation | 1 | 2009 | 821 | 0.010 |
Why?
|